FMP

FMP

Enter

DARE - Daré Bioscience, Inc...

Financial Summary of Daré Bioscience, Inc.(DARE), Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, devel

photo-url-https://financialmodelingprep.com/image-stock/DARE.png

Daré Bioscience, Inc.

DARE

NASDAQ

Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company's Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar and vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan, as well as DARE-PTB1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ADARE-204 and ADARE-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women. The company entered into license agreement with Organon & Co. and Organon International GmbH to commercialize XACIATO. Daré Bioscience, Inc. is headquartered in San Diego, California.

0.48 USD

0.0107 (2.23%)

About

ceo

Ms. Sabrina Martucci Johnson

sector

Healthcare

industry

Biotechnology

website

https://www.darebioscience.com

exchange

NASDAQ

Description

Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal diso...

CIK

0001401914

ISIN

US23666P1012

CUSIP

23666P101

Address

3655 Nobel Drive

Phone

858 926 7655

Country

US

Employee

23

IPO Date

Apr 10, 2014

Summary

CIK

0001401914

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

23666P101

ISIN

US23666P1012

Country

US

Price

0.48

Beta

1.21

Volume Avg.

367.77k

Market Cap

48.29M

Shares

-

52-Week

0.27-1.1

DCF

0.09

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.37

P/B

-

Website

https://www.darebioscience.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest DARE News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep